61 related articles for article (PubMed ID: 11220523)
1. Rosiglitazone.
Diabetes Obes Metab; 2000 Apr; 2(2):117. PubMed ID: 11220523
[No Abstract] [Full Text] [Related]
2. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
[No Abstract] [Full Text] [Related]
3. Rosiglitazone--useful drug but has side effects.
Vidhya S; Mohan V
J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
[No Abstract] [Full Text] [Related]
4. Accelerated hypertension due to rosiglitazone therapy.
Vikram NK; Misra A; Devi JR
Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195
[No Abstract] [Full Text] [Related]
5. Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.
Wooltorton E
CMAJ; 2002 Jan; 166(2):219. PubMed ID: 11826947
[No Abstract] [Full Text] [Related]
6. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
7. Warner-Lambert voluntarily withdraws Rezulin.
Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
[No Abstract] [Full Text] [Related]
8. Rosiglitazone in the management of older patients with type 2 diabetes mellitus.
Kreider M; Heise M
Int J Clin Pract; 2002 Sep; 56(7):538-41. PubMed ID: 12296617
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone and hepatic failure.
Freid J; Everitt D; Boscia J
Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
[No Abstract] [Full Text] [Related]
10. The chase is on (and I'm mad as hell).
Ponte CD
J Am Pharm Assoc (Wash); 2000; 40(4):466. PubMed ID: 10932454
[No Abstract] [Full Text] [Related]
11. Correction: Liver injury and rosiglitazone.
Ann Intern Med; 2000 Aug; 133(3):237. PubMed ID: 10906846
[No Abstract] [Full Text] [Related]
12. Rosiglitazone toxicity.
Ravinuthala RS; Nori U
Ann Intern Med; 2000 Oct; 133(8):658. PubMed ID: 11033603
[No Abstract] [Full Text] [Related]
13. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
14. Thiazolidinediones and liver toxicity.
Scheen AJ
Diabetes Metab; 2001 Jun; 27(3):305-13. PubMed ID: 11431595
[TBL] [Abstract][Full Text] [Related]
15. Liver failure in a patient treated with long-term rosiglitazone therapy.
Gouda HE; Khan A; Schwartz J; Cohen RI
Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
[No Abstract] [Full Text] [Related]
16. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
17. Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
Hachey DM; O'Neil MP; Force RW
Ann Intern Med; 2000 Nov; 133(9):752. PubMed ID: 11074926
[No Abstract] [Full Text] [Related]
18. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
McMorran M; Vu D
CMAJ; 2001 Jul; 165(1):82-3, 86-7. PubMed ID: 11468963
[No Abstract] [Full Text] [Related]
19. New labeling and use changes for Rezulin.
Klonoff DC
Diabetes Technol Ther; 1999; 1(3):350. PubMed ID: 11484719
[No Abstract] [Full Text] [Related]
20. Glitazones, glycemia, and global health status.
Isley WL
Diabetes Care; 2001 Dec; 24(12):2158-9. PubMed ID: 11723105
[No Abstract] [Full Text] [Related]
[Next] [New Search]